| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P6179 | Dimensions Publication ID | 1011386634 |
| P356 | DOI | 10.1038/354476A0 |
| P953 | full work available at URL | https://www.nature.com/articles/354476a0 |
| https://www.nature.com/articles/354476a0.pdf | ||
| P698 | PubMed publication ID | 1793460 |
| P2093 | author name string | Gordon JW | |
| Higgins GA | |||
| Kawabata S | |||
| P2860 | cites work | Site-directed mutagenesis with Escherichia coli DNA polymerase III holoenzyme | Q68139595 |
| Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage | Q69282065 | ||
| Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain | Q69300892 | ||
| Regulation of Thy-1 gene expression in transgenic mice | Q69902613 | ||
| Advances in Alzheimer's disease | Q70113819 | ||
| Gene transfer into mouse embryos: production of transgenic mice by pronuclear injection | Q70912216 | ||
| Genetic transformation of mouse embryos by microinjection of purified DNA | Q24608157 | ||
| Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 | ||
| Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein | Q29547803 | ||
| Ribonucleic acid isolated by cesium chloride centrifugation | Q29616561 | ||
| The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor | Q29618322 | ||
| Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease | Q33554847 | ||
| Integration and Stable Germ Line Transmission of Genes Injected into Mouse Pronuclei | Q34252877 | ||
| Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease | Q34415666 | ||
| Differential regulation of a Thy-1 gene in transgenic mice | Q34604121 | ||
| A human beta-actin expression vector system directs high-level accumulation of antisense transcripts | Q34638492 | ||
| NGF induction of NGF receptor gene expression and cholinergic neuronal hypertrophy within the basal forebrain of the adult rat. | Q42494413 | ||
| Should a unified nomenclature be adopted for the amyloid protein of Alzheimer's disease? | Q43858195 | ||
| Deposits of Amyloid β Protein in the Central Nervous System of Transgenic Mice | Q43905949 | ||
| Formation of beta-amyloid protein deposits in brains of transgenic mice | Q44671370 | ||
| Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. | Q52112673 | ||
| Cerebral amyloidosis, ageing and Alzheimer's disease; a contribution from studies on Down's syndrome. | Q53187253 | ||
| Ultrastructural studies of the cells forming amyloid fibers in classical plaques. | Q53187413 | ||
| Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. | Q53187594 | ||
| Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging. | Q53191866 | ||
| Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. | Q54132974 | ||
| P433 | issue | 6353 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | overexpression | Q61643320 |
| P304 | page(s) | 476-478 | |
| P577 | publication date | 1991-12-01 | |
| 1991-12-12 | |||
| P1433 | published in | Nature | Q180445 |
| P1476 | title | RETRACTED ARTICLE: Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein | |
| P478 | volume | 354 |
| Q48435028 | A novel correlation between the levels of beta-amyloid protein precursor and tau transcripts in the aged human brain |
| Q100723149 | A review on preventive role of ketogenic diet (KD) in CNS disorders from the gut microbiota perspective |
| Q41067448 | APP transgenesis: approaches toward the development of animal models for Alzheimer disease neuropathology |
| Q48380704 | Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged |
| Q42755862 | Accumulation of amyloid precursor protein in neurons after intraventricular injection of colchicine |
| Q36044202 | Adult-onset focal expression of mutated human tau in the hippocampus impairs spatial working memory of rats |
| Q36307331 | Advances and retreats in the molecular genetics of major mental illness |
| Q36410134 | Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses |
| Q30499574 | Alzheimer disease models and human neuropathology: similarities and differences |
| Q53207212 | Alzheimer's as a common complex disease. |
| Q67583873 | Alzheimer's disease |
| Q48508983 | Alzheimer's disease and amyloid |
| Q48226501 | Alzheimer's disease and transgenic mice. |
| Q40533051 | Alzheimer's disease--from cause to cure? |
| Q46084123 | Alzheimer's disease. In the beginning... |
| Q40719374 | Alzheimer's disease: molecular genetics and transgenic animal models |
| Q35687044 | Alzheimer's disease: pathological mechanisms and recent insights |
| Q35303922 | Alzheimer's disease: transgenic models to test new chemicals and pharmaceuticals |
| Q60063321 | Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein |
| Q35469458 | Amyloidogenesis in Alzheimer's disease: basic biology and animal models |
| Q36061994 | Amyloidogenesis in Alzheimer's disease: some possible therapeutic opportunities |
| Q35443377 | Amyloidosis in aging and Alzheimer's disease |
| Q35854653 | Animal and drug modelling for Alzheimer synaptic pathology |
| Q40701616 | Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease |
| Q36560563 | Artificial chromosome-based transgenes in the study of genome function |
| Q37236361 | Association between ABCB1 polymorphisms and haplotypes and Alzheimer's disease: a meta-analysis |
| Q35230344 | Attempts to make models for Alzheimer's disease |
| Q35472168 | Aβ induces PUMA activation: a new mechanism for Aβ-mediated neuronal apoptosis |
| Q40810047 | Biochemistry of Alzheimer's disease amyloid plaques |
| Q40840457 | Biotechnology in the drug discovery process: strategic and management issues |
| Q40759701 | Cellular and molecular biology of Alzheimer's disease and animal models |
| Q37442265 | Cited references and Medical Subject Headings (MeSH) as two different knowledge representations: clustering and mappings at the paper level |
| Q41442412 | Combined administration of D-galactose and aluminium induces Alzheimer-like lesions in brain |
| Q40807678 | Complex genetic disease: can genetic strategies in Alzheimer's disease and new genetic mechanisms be applied to epilepsy? |
| Q46563535 | Correlation of Alzheimer-like tau hyperphosphorylation and fMRI bold intensity |
| Q30978251 | Correlation of behavior changes and BOLD signal in Alzheimer-like rat model |
| Q47167624 | Energetics of Excitatory and Inhibitory Neurotransmission in Aluminum Chloride Model of Alzheimer's Disease: Reversal of Behavioral and Metabolic Deficits by Rasa Sindoor |
| Q41729907 | Experimental and clinical methods in the development of anti-Alzheimer drugs |
| Q64234862 | Expression Profiles of Long Noncoding RNAs in Intranasal LPS-Mediated Alzheimer's Disease Model in Mice |
| Q41596961 | Expression of a carboxy-terminal region of the beta-amyloid precursor protein in a heterogeneous culture of neuroblastoma cells: evidence for altered processing and selective neurotoxicity |
| Q48161830 | Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol |
| Q34343432 | Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected] |
| Q36603312 | Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice |
| Q26740231 | Long noncoding RNAs and Alzheimer's disease |
| Q53201861 | Making models for Alzheimer's disease. |
| Q35477277 | Mapping hydrophobicity on the protein molecular surface at atom-level resolution |
| Q40443903 | Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging |
| Q41422671 | Murine models of brain aging and age-related neurodegenerative diseases |
| Q36882830 | Neurodegeneration and gliosis in transgenic mice overexpressing a carboxy-terminal fragment of Alzheimer amyloid-beta protein precursor |
| Q35615493 | Neuronal degeneration in human diseases and animal models |
| Q37873254 | Neurotrophic factors in development and plasticity of spinal neurons. |
| Q40167021 | Overexpression of amyloid precursor protein reduces epsilon protein kinase C levels |
| Q42289189 | Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates |
| Q28487985 | Protein molecular surface mapped at different geometrical resolutions |
| Q40782240 | Subacute spongiform encephalopathies--the transmissible brain amyloidoses: a comparison with the non-transmissible brain amyloidoses of Alzheimer type |
| Q43889957 | The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice |
| Q40425515 | The Role of β-Amyloid in the Development of Alzheimerʼs Disease |
| Q34764030 | The adipocyte differentiation protein APMAP is an endogenous suppressor of Aβ production in the brain |
| Q36349347 | The etiology of Alzheimer's disease: the pathogenesis of dementia. The role of neurotoxins |
| Q35753836 | The first decade of molecular genetics in neurology: changing clinical thought and practice |
| Q60301954 | The influence of GAPT extraction on synapse loss of APPswe/PS1dE9 transgenic mice via adjusting Bcl-2/Bax balance |
| Q35274305 | The molecular pathogenesis of Alzheimer's disease: clinical prospects |
| Q48407938 | The pathology of the neuronal cytoskeleton in Alzheimer's disease |
| Q70850150 | The potential utility of transgenic mice harboring beta-amyloid precursor protein |
| Q35263353 | The role of amyloid beta-protein in Alzheimer's disease |
| Q40668789 | Transgenic and knock-out mice: models of neurological disease. |
| Q40779631 | Transgenic animal models for Alzheimer's disease |
| Q40947107 | Transgenic mice and modeling Alzheimer's disease |
| Q58270048 | Transgenic mice in amyloid research: an interpretive review |
| Q33844718 | Transgenic models of Alzheimer's disease: learning from animals |
| Q35170198 | What can rodent models tell us about cognitive decline in Alzheimer's disease? |
| Q77781796 | Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein |
Search more.